Skip to main content
    P

    Pulmatrix Inc (PULM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.29
    -0.01 (-0.76%)

    Market Cap: $4.71M

    Last updated: Nov 17, 2026 at 10:46 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(19/28)
    Avg Surprise
    +16.81%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-98.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.32xQuick Ratio2.32x
    Trading Statistics
    Beta1.92Avg Volume36.82K
    52-Week High$4.9452-Week Low$1.06

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 11.6% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 40.4, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.36
    SMA 20$1.41
    SMA 50$1.46
    SMA 200$1.65
    EMA 10$1.35
    EMA 20$1.39
    EMA 50$1.45
    EMA 200$1.98

    MACD

    Line: -0.04Signal: -0.03Hist: -0.01

    ADX

    ADX: 24.8+DI: 10.2-DI: 20.9

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down72.0
    PSAR$1.40

    Bollinger Bands

    Upper Band$1.56
    Lower Band$1.26
    %B Position2152%(Upper)
    Band Width0.10

    RSI (14-Day)

    Neutral
    40.4

    Momentum Oscillators

    Stoch %K48.0
    Stoch %D51.3
    Williams %R-54.0
    ROC (10d)-7.9%
    Momentum-0.11
    CCI (20d)-165.0
    MFI (14d)73.9

    Volatility Measures

    ATR (14d)$0.13(10.3%)
    StdDev (20d)0.08
    Hist Vol88.0%(High)

    Volume Flow

    VWAP$1.28
    OBV-2.2M
    AD Line-933.6K
    CMF (20d)0.273

    Volume Metrics

    Avg Vol (20d)38.6K
    Vol Ratio0.2x(Low)
    VWMA (20d)$1.47

    Pivot Points

    R3$1.47
    R2$1.41
    R1$1.35
    Pivot Point$1.29
    S1$1.23
    S2$1.17
    S3$1.11

    Advanced Oscillators

    TSI-11.56
    Ultimate Osc48.6
    KST-69.05

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about PULM

    News

    PULM Profitability: Margins, ROIC and FCF

    Pulmatrix (PULM) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -98.4%
    PULM financial statements

    Pulmatrix Competitors

    The companies most similar to Pulmatrix (PULM) include Processa Pharmaceuticals, Liminatus Pharma, Inc. Class A Common Stock and Aprea Therapeutics.

    Sector: Healthcare

    Companies most similar to Pulmatrix

    PULM Bull Case vs Bear Case

    Bull case

    • PULM beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • PULM's quarterly revenue changed -99.9% year over year.

    PULM Earnings: Beat Rate

    Pulmatrix (PULM) beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate (75.0%). Its next report is expected on Feb 24, 2027.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    11.9%
    PULM earnings history

    PULM Earnings Date

    PULM reports Feb 24, 2027. The date is estimated.

    See insider activity

    Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About PULM

    When does PULM report earnings?

    Pulmatrix Inc (PULM) is expected to report earnings on Feb 24, 2027.

    Does PULM pay dividends?

    Pulmatrix Inc (PULM) does not currently pay a regular dividend.

    What is PULM's market cap?

    Pulmatrix Inc (PULM) has a market capitalization of $4.71M with a current stock price of $1.29.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.